Double Medical Technology Inc
SZSE:002901
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
22.17
40.62
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Double Medical Technology Inc
Income from Continuing Operations
Double Medical Technology Inc
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Double Medical Technology Inc
SZSE:002901
|
Income from Continuing Operations
ÂĄ135.4m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
||
A
|
APT Medical Inc
SSE:688617
|
Income from Continuing Operations
ÂĄ522.1m
|
CAGR 3-Years
71%
|
CAGR 5-Years
99%
|
CAGR 10-Years
N/A
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Income from Continuing Operations
ÂĄ1.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
16%
|
CAGR 10-Years
19%
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Income from Continuing Operations
ÂĄ12.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
||
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
Income from Continuing Operations
ÂĄ794.1m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Income from Continuing Operations
ÂĄ2B
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Double Medical Technology Inc
Glance View
Double Medical Technology, Inc. engages in production, research and development and sale of medical consumables. The company is headquartered in Xiamen, Fujian and currently employs 3,141 full-time employees. The company went IPO on 2017-09-22. The main products of the Company include orthopedic trauma implant materials, spinal implant materials and nerve surgical implant materials. Also, the Company manufactures surgical instruments. The firm distributes its products in domestic and overseas markets.
See Also
What is Double Medical Technology Inc's Income from Continuing Operations?
Income from Continuing Operations
135.4m
CNY
Based on the financial report for Jun 30, 2024, Double Medical Technology Inc's Income from Continuing Operations amounts to 135.4m CNY.
What is Double Medical Technology Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-20%
Over the last year, the Income from Continuing Operations growth was 504%. The average annual Income from Continuing Operations growth rates for Double Medical Technology Inc have been -41% over the past three years , -20% over the past five years .